SCHEMBL8709063

SCHEMBL8709063

[CH2]Cc1ccccc1NS(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PTGS1 P23219 1/20 0.48
NFE2L2 Q16236 1/20 0.47
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.46
RCE1 Q9Y256 1/20 0.46
KMT2A Q03164 1/20 0.45
HPGD P15428 2/20 0.43
EP300 Q09472 1/20 0.43
KAT2B Q92831 1/20 0.43
KAT8 Q9H7Z6 1/20 0.43
GAA P10253 1/20 0.42
NR3C1 P04150 3/20 0.42
PGR P06401 2/20 0.42
NR3C2 P08235 2/20 0.42
AR P10275 2/20 0.42
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
GLO1 Q04760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5186762 0.84 PTGS1 (0.62) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL27811591 0.82 KEAP1 (0.52) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL4866296 0.81 KEAP1 (0.50) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL19567904 0.81 KEAP1 (0.50) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL4963565 0.81 KEAP1 (0.55) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL8420054 0.80 KEAP1 (0.46) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
Hydrochloric Acid SCHEMBL15225007 0.79 KEAP1 (0.49) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL3715386 0.79 PLA2G7 (0.54) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL2068498 0.79 KEAP1 (0.65) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1
SCHEMBL29904739 0.79 KEAP1 (0.65) KEAP1L3MBTL1PTGS1NFE2L2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed